UnknownPhase 2

Efficacy of Oral Ibandronate in Osteoporosis

Japan100 participantsStarted 2017-10-12

Plain-language summary

There has been no comparative data between oral ibandronate and oral ibandronate plus active vitamin D

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Osteoporotic patients who want to take oral ibandronate Exclusion Criteria: * Patients who are allergic to oral ibandronate or vitamin D Patients who have not taken oral ibandronate for the last 2 years

What they're measuring

Bone mineral density

Timeframe: Change from Baseline Values at 1 year

Trial details

NCT IDNCT03186131

SponsorShinshu University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-08

View on ClinicalTrials.gov More Osteoporosis trials